Page 73 - Read Online

carcinogenesis by dietary polyphenolic compounds. Ann Rev Nutr 29. Chen W, Kozielski R, LeVea C, Chen F. The advances in molecular
2001;21:381-406. biology of hepatoblastoma: implications for diagnostic pathology. N
7. Mann CD, Neal CP, Garcea G, Manson MM, Dennison AR, Berry DP. A J Med Sci 2012;5:217-23.
Phytochemicals as potential chemopreventive and chemotherapeutic 30. Adesina AM, Lopez-Terrada D, Wong KK, Gunaratne P, Nguyen Y,
agents in hepatocarcinogenesis. Eur J Cancer Prev 2009;18:13-25. Pulliam J, Margolin J, Finegold MJ. Gene expression profiling reveals
8. Jacob A, Wu R, Zhou M, Wnag P. Mechanism of anti-inflammatory signatures characterizing histologic subtypes of hepatoblastoma
effect of curcumin: PPAR-gamma activation. PPAR Res 2007;2007:1- and global deregulation in cell growth and survival pathways. Hum
5. Pathol 2009;40:843-53.
9. Sandhur SK, Ichikawa H, Pandey MK, Kunnumakkara AB, Sung 31. Cairo S, Armengol C, Buendia MA. Activation of Wnt and Myc
B, Sethi G, Kunnumakkara AB, Aggarwal BB. Role of pro-oxidants signaling in hepatoblastoma. Front Biosci (Elite Ed) 2012;4:480-6.
and antioxidants in the anti-inflammatory and apoptotic effects of 32. Spiegelman VS, Slaga TJ, Pagano M, Minamoto T, Ronai Z, Fuchs
curcumin (diferuloylmethane). Free Radic Biol Med 2007;43:568- SY. Wnt/beta-catenin signaling induces the expression and activity of
80. betaTrCP ubiquitin ligase receptor. Mol Cell 2000;5:877-82.
10. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits 33. López-Terrada D, Gunaratne PH, Adesina AM, Pulliam J, Hoang
proliferation, invasion, angiogenesis and metastasis of different DM, Nguyen Y , Mistretta TA, Margolin J, Finegold MJ. Histologic
cancers through interaction with multiple cell signaling proteins. subtypes of hepatoblastoma are characterized by differential
Cancer Lett 2008;269:199-225. canonical Wnt and Notch pathway activation in DLK+ precursors.
11. Ricky AS, Stephanie AE, Sharon LP. Phase I clinical trial of oral Hum Pathol 2009;40:783-94.
curcumin: biomarkers of systemic activity and compliance. Clin 34. Ranganathan S, Tan X, Monga SP. Beta-catenin and met deregulation
Cancer Res 2004;10:6847-54. in childhood hepatoblastomas. Pediatr Dev Pathol 2005;8:435-47.
12. Suryanarayana P, Satyanarayana A, Balakrishna N, Kumar PU, 35. Park WS, Oh RR, Park JY, Kim PJ, Shin MS, Lee JH , Kim HS, Lee
Reddy GB. Effect of turmeric and curcumin on oxidative stress and SH, Kim SY, Park YG, An WG, Kim HS, Jang JJ, Yoo NJ, Lee JY.
antioxidant enzymes in streptozotocin-induced diabetic rat. Med Sci Nuclear localization of beta-catenin is an important prognostic factor
Monit 2007;13:BR286-92. in hepatoblastoma. J Pathol 2001;193:483-90.
13. Sreejayan, Rao MN. Curcuminoids as potent inhibitors of lipid 36. Krawczuk-Rybak M, Jakubiuk-Tomaszuk A, Skiba E, Plawski
peroxidation. J Pharm Pharmacol 1994;46:1013-6. A. Hepatoblastoma as a result of APC gene mutation. J Pediatr
14. Michalopoulos GK. Liver regeneration. J Cell Physiol 2007;213:286- Gastroenterol Nutr 2012;55:334-6.
300. 37. Ueda Y, Hiyama E, Kamimatsuse A, Kamei N, Ogura K, Sueda
15. Alison MR. Liver stem cells: implications for hepatocarcinogenesis. T. Wnt signaling and telomerase activation of hepatoblastoma:
Stem Cell Rev 2005;1:253-60. correlation with chemosensitivity and surgical resectability. J Pediatr
16. Katoh M. WNT signaling pathway and stem cell signaling network. Surg 2011;46:2221-7.
Clin Cancer Res 2007;13:4042-5. 38. Armengol C, Cairo S, Fabre M, Buendia MA. Wnt signaling and
17. Oishi N, Wang XW. Novel therapeutic strategies for targeting liver hepatocarcinogenesis: the hepatoblastoma model. Int J Biochem Cell
cancer stem cells. Int J Biol Sci 2011;7:517-35. Biol 2011;43:265-70.
18. Trzpis M, McLaughlin PM, de Leij LM, Harmsen MC. Epithelial 39. Purcell R, Childs M, Maibach R, Miles C, Turner C, Zimmermann
cell adhesion molecule: more than a carcinoma marker and adhesion A , Sullivan M. HGF/c-Met related activation of β-catenin in
molecule. Am J Pathol 2007;171:386-95. hepatoblastoma. J Exp Clin Cancer Res 2011;30:96.
19. Yamashita T, Budhu A, Forgues M, Wang XW. Activation of 40. Litten JB, Chen TT, Schultz R, Herman K, Comstock J, Tomlinson GE,
hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in Rakheja D. Activated NOTCH2 is overexpressed in hepatoblastomas:
hepatocellular carcinoma. Cancer Res 2007;67:10831-9. an immunohistochemical study. Pediatr Dev Pathol 2011;14:378-83.
20. Reya T, Clevers H. Wnt signaling in stem cells and cancer. Nature 41. Sicklick JK, Li YX, Jayaraman A, Kannangai R, Qi Y,
2005;434:843-50. Vivekanandan P , Ludlow JW, Owzar K, Chen W, Torbenson MS,
21. Ishizaki Y, Ikeda S, Fujimori M, Shimizu Y, Kurihara T, Itamoto T, Diehl AM. Dysregulation of the Hedgehog pathway in human
Kikuchi A, Okajima M, Asahara T. Immunohistochemical analysis hepatocarcinogenesis. Carcinogenesis 2006;27:748-57.
and mutational analyses of beta-catenin, Axin family and APC genes 42. Eichenmüller M, Gruner I, Hagl B, Haberle B, Muller-Hocker J, von
in hepatocellular carcinomas. Int J Oncol 2004;24:1077-83. Schweinitz D, Kappler R. Blocking the hedgehog pathway inhibits
22. Yong KJ, Chai L, Tenen DG. Oncofetal gene SALL4 in aggressive hepatoblastoma growth. Hepatology 2009;49:482-90.
hepatocellular carcinoma. N Engl J Med 2013;369:1171-2. 43. Ziegler DS, Kung AL. Therapeutic targeting of apoptosis pathways in
23. Zeng SS, Yamashita T, Kondo M, Nio K, Hayashi T, Hara Y Nomura cancer. Curr Opin Oncol 2008;20:97-103.
Y, Yoshida M, Hayashi T, Oishi N, Ikeda H, Honda M, Kaneko S. The 44. Liu H, Liang Y, Wang L, Tian L, Song R, Han T , Pan S, Liu L. In
transcription factor SALL4 regulates stemness of EpCAM-positive vivo and in vitro suppression of hepatocellular carcinoma by EF24, a
hepatocellular carcinoma. J Hepatol 2014;60:127-34. curcumin analog. PLoS One 2012;7:e48075.
24. Tang Y, Kitisin K, Jogunoori W, Li C, Deng CX, Mueller SC, Ressom 45. Yu J, Zhou X, He X, Dai M, Zhang Q. Curcumin induces apoptosis
HW, Rashid A, He AR, Mendelson JS, Jessup JM, Shetty K, Zasloff involving bax/bcl-2 in human hepatoma SMMC-7721 cells. Asian
M, Mishra B, Reddy EP, Johnson L, Mishra L. Progenitor/stem cells Pac J Cancer Prev 2011;12:1925-9.
give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling. 46. Wang WZ, Cheng J, Luo J, Zhuang SM. Abrogation of G2/M arrest
Proc Natl Acad Sci USA 2008;105:2445-50. sensitizes curcumin-resistant hepatoma cells to apoptosis. FEBS Lett
25. Yuan F, Zhou W, Zou C, Zhang Z, Hu H, Dai Z, Zhang Y. Expression 2008;582:2689-95.
of Oct4 in HCC and modulation to wnt/β-catenin and TGF-β signal 47. Dai X, Yin H, Sun L, Hu X, Zhou C, Zhou Y Zhang W, Huang XE, Li
pathways. Mol Cell Biochem 2010;343:155-62. XC. Potential therapeutic efficacy of curcumin in liver cancer. Asian
26. Weng AP, Aster JC. Multiple niches for Notch in cancer: context is Pac J Cancer Prev 2013;14:3855-9.
everything. Curr Opin Genet Dev 2004;14:48-54. 48. Jung EM, Lim JH, Lee TJ, Park JW, Choi KS, Kwon TK. Curcumin
27. Androutsellis-Theotokis A, Leker RR, Soldner F, Hoeppner DJ, sensitizes tumor necrosis factor-related apoptosis-inducing ligand
Ravin R, Poser SW, Rueger MA, Bae SK, Kittappa R, McKay RD. (TRAIL)-induced apoptosis through reactive oxygen species-
Notch signaling regulates stem cell numbers in vitro and in vivo. mediated upregulation of death receptor 5 (DR5). Carcinogenesis
Nature 2006;442:823-6. 2005;26:1905-13.
28. Villavicencio EH, Walterhouse DO, Iannaccone PM. The sonic 49. Ashkenzi A, Dixit VM. Apoptosis control by death and decoy
hedgehog-patched-gli pathway in human development and disease. receptors. Curr Opin Cell Biol 1999;11:255-60.
Am J Hum Genet 2000;67:1047-54. 50. Yin L, Velazquez OC, Liu ZJ. Notch signaling emerging molecular

Hepatoma Research | Volume 2 | March 9, 2016 69